Tumor aneuploidy as a prognostic and predictive biomarker in immune checkpoint blockade Summary Tumor aneuploidy, an abnormal chromosome number, is increasingly recognized as a crucial factor influencing cancer progression and response to immunotherapy, particularly immune Read More